Indication

Juvenile myelomonocytic leukemia

Juvenile myelomonocytic leukemia is a rare, aggressive hematopoietic malignancy of infancy and early childhood classified as an overlap myelodysplastic and myeloproliferative neoplasm. Read more about Juvenile myelomonocytic leukemia

24 drugs 24 manufacturers

Advertisement

Drugs that treat it

Common Juvenile myelomonocytic leukemia therapies.

Showing 10–18 of 24 drugs

AZACITIDINE

PYRIMIDINE ANALOGS·MYELODYSPLASTIC SYNDROME·+2
NORTHSTAR RX LL

AZACITIDINE

PYRIMIDINE ANALOGS·MYELODYSPLASTIC SYNDROME·+2
ACCORD HEALTHCA

AZACITIDINE

PYRIMIDINE ANALOGS·MYELODYSPLASTIC SYNDROME·+2
ARMAS PHARMACEU

AZACITIDINE

PYRIMIDINE ANALOGS·MYELODYSPLASTIC SYNDROME·+2
DR.REDDY'S LAB

AZACITIDINE

PYRIMIDINE ANALOGS·MYELODYSPLASTIC SYNDROME·+2
APOTEX CORP

AZACITIDINE

PYRIMIDINE ANALOGS·MYELODYSPLASTIC SYNDROME·+2
MEITHEAL PHARMA
Filter & compare in the drug finder →Opens the drug finder with Juvenile myelomonocytic leukemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Juvenile myelomonocytic leukemia.

Juvenile myelomonocytic leukemia is a rare, aggressive hematopoietic malignancy of infancy and early childhood classified as an overlap myelodysplastic and myeloproliferative neoplasm.

The condition primarily targets the hematopoietic system, resulting in the excessive, clonal proliferation of immature myelomonocytic cells within the bone marrow and peripheral circulation.

Pathophysiologically, it is driven in the vast majority of cases by somatic or germline mutations that cause hyperactivation of the RAS/MAPK signaling pathway and selective hypersensitivity of myeloid progenitor cells to granulocyte-macrophage colony-stimulating factor.

Clinically, affected children typically present with persistent peripheral monocytosis, cytopenias, elevated fetal hemoglobin levels, and leukemic organ infiltration manifesting as pronounced hepatosplenomegaly, lymphadenopathy, and cutaneous rashes.

Personalize your experience

Follow Juvenile myelomonocytic leukemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it